Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug ...
Kezar Life Sciences reports positive Phase 2a data for zetomipzomib in autoimmune hepatitis, showing higher response rates and reduced steroid use.
MarketBeat on MSN2 小时
Top 3 Insider Stock Buys in March-Are They Still Good in April?
Tenaya Therapeutics (NASDAQ: TNYA), and FirstSun Capital Bancorp (NASDAQ: FSUN) in March. These companies rank high, if not ...
Cibc World Markets Corp Acquires Shares of 21,076 ADMA Biologics, Inc. (NASDAQ:ADMA)
Cibc World Markets Corp bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and ...
Barron's Bounce: Sarepta's Soaring Fortunes
The biotech stock's shares surged after Barron's said the market is underestimating potential sales of its Duchenne Muscular ...
Here's Why GM Shares Are Zooming Higher
Two auto-related stocks are up sharply after recommendations in Barron's. Plus: A little-known biotech soars 21% after a ...
From $6 billion unicorn to bankrupt cautionary tale: The story of 23andMe
DNA testing company 23andMe was a white-hot Silicon Valley startup for years, and Anne Wojcicki was a celebrity CEO. But ...
Cashing in on Copper: 6 Smart Ways Penny Extinction Pays You
The humble one-cent piece is fading into history, potentially creating lucrative opportunities for the financially savvy. Discover these strategies to benefit from this monetary transition.